Immunohistochemical Double-Hit Score is a Strong Predictor of Outcome in Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Tina Green; Ken Young; Carlo  Visco; zijun  Xu-Monette; Attilio Orazi; Ronald  Go; Ole  Nielsen; Ole Vestergaard Gadeberg; Torben  Mourits-Andersen; Mikael Frederiksen; Lars Møller Pedersen; Michael Boe Møller

Immunohistochemical Double-Hit Score is a Strong Predictor of Outcome in Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Tina Green, Ken Young, Carlo Visco, zijun Xu-Monette, Attilio Orazi, Ronald Go, Ole Nielsen, Ole Vestergaard Gadeberg, Torben Mourits-Andersen, Mikael Frederiksen, Lars Møller Pedersen, Michael Boe Møller

Research output: Contribution to journal › Journal article › Research › peer-review

Original language	English
Journal	Journal of Clinical Oncology
Volume	30
Issue number	28
Pages (from-to)	3460-7
Number of pages	8
ISSN	0732-183X
Publication status	Published - 2012

Cite this

Green, T., Young, K., Visco, C., Xu-Monette, Z., Orazi, A., Go, R., Nielsen, O., Gadeberg, O. V., Mourits-Andersen, T., Frederiksen, M., Pedersen, L. M., & Møller, M. B. (2012). Immunohistochemical Double-Hit Score is a Strong Predictor of Outcome in Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone. Journal of Clinical Oncology, 30(28), 3460-7.

@article{3bfb17165f9f42ca9cf253c3e0f97f40,

title = "Immunohistochemical Double-Hit Score is a Strong Predictor of Outcome in Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone",

keywords = "MYC, Double Hit, Lymfom",

author = "Tina Green and Ken Young and Carlo Visco and zijun Xu-Monette and Attilio Orazi and Ronald Go and Ole Nielsen and Gadeberg, {Ole Vestergaard} and Torben Mourits-Andersen and Mikael Frederiksen and Pedersen, {Lars M{\o}ller} and M{\o}ller, {Michael Boe}",

year = "2012",

language = "English",

volume = "30",

pages = "3460--7",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "28",

}

Green, T, Young, K, Visco, C, Xu-Monette, Z, Orazi, A, Go, R, Nielsen, O, Gadeberg, OV, Mourits-Andersen, T, Frederiksen, M, Pedersen, LM & Møller, MB 2012, 'Immunohistochemical Double-Hit Score is a Strong Predictor of Outcome in Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone', Journal of Clinical Oncology, vol. 30, no. 28, pp. 3460-7.

Immunohistochemical Double-Hit Score is a Strong Predictor of Outcome in Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone. / Green, Tina; Young, Ken; Visco, Carlo et al.
In: Journal of Clinical Oncology, Vol. 30, No. 28, 2012, p. 3460-7.

Research output: Contribution to journal › Journal article › Research › peer-review

TY - JOUR

T1 - Immunohistochemical Double-Hit Score is a Strong Predictor of Outcome in Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

AU - Green, Tina

AU - Young, Ken

AU - Visco, Carlo

AU - Xu-Monette, zijun

AU - Orazi, Attilio

AU - Go, Ronald

AU - Nielsen, Ole

AU - Gadeberg, Ole Vestergaard

AU - Mourits-Andersen, Torben

AU - Frederiksen, Mikael

AU - Pedersen, Lars Møller

AU - Møller, Michael Boe

PY - 2012

Y1 - 2012

KW - MYC, Double Hit, Lymfom

M3 - Journal article

SN - 0732-183X

VL - 30

SP - 3460

EP - 3467

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 28

ER -